Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
G/S checkpoint Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Mitotic Kinase Inhibitors
Gaps Application Of The Hallmarks Of Cancer Targeting Angiogenesis
Gastric cancer, EGFR overexpression in Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Gastrointestinal perforation, antiangiogenic drugs, nursing considerations and
Gastrointestinal stromal tumor
Gastrulation, in the embryo, with germ layers
GDC-0449 Protein Kinase Inhibitors Protein Kinase Signaling Pathways
Gefitinib (Iressa, ZD1839)
Gemcitabine Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information Protein Kinase Inhibitors Protein Kinase Signaling Pathways References (Chapter 4)
Gemtuzumab ozogamicin for injection (Mylotarg) adverse reactions available as black box warnings class dosage and administration drug interactions indications mechanism of action Monoclonal Antibodies nursing discussion pharmacokinetics reconstitution and preparation warnings
Gene activity, epigenetic code and control of
Gene expression Application Of The Hallmarks Of Cancer Bone Metastasis Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Epigenetics Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Inhibitors References References (Chapter 2)
Gene product Application Of The Hallmarks Of Cancer Glossary Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Mitotic Kinase Inhibitors
Genes
Genetic mutations Application Of The Hallmarks Of Cancer Chapter 1. Cancer Biology, Signaling Pathways, and Malignant Transformation Hallmarks Of Cancer Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Gene
Germ tissue types
Giordano, A.
GIST,
Giuliani, N.
Gleevec,
Glioblastoma (GBM, glioblastoma multiforme, grade IV astrocytoma), EGFR overexpression in Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Golgi apparatus
G phase Application Of The Hallmarks Of Cancer entrance into G and
G phase, entrance into
G phase, G phase and entrance into
Green tea/green tea extracts, bortezomib and
Growth factor receptors Application Of The Hallmarks Of Cancer Hypoxia-Inducible Factor, Mtor, and Angiogenesis Invasion and Metastasis Protein Kinase Signaling Pathways References (Chapter 3)
Growth factors
Growth-inhibitory pathways